224 related articles for article (PubMed ID: 36923226)
1. A novel prognostic model for patients with colon adenocarcinoma.
Yin C; Wang W; Cao W; Chen Y; Sun X; He K
Front Endocrinol (Lausanne); 2023; 14():1133554. PubMed ID: 36923226
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of prognostic nomograms for early-onset colon cancer in different tumor locations: a population-based study.
Zhu S; Tu J; Pei W; Zheng Z; Bi J; Feng Q
BMC Gastroenterol; 2023 Oct; 23(1):362. PubMed ID: 37865754
[TBL] [Abstract][Full Text] [Related]
3. Epidemiological trends and novel prognostic evaluation approaches of patients with stage II-IV colorectal neuroendocrine neoplasms: A population-based study with external validation.
Zhao F; Huang L; Wang Z; Wei F; Xiao T; Liu Q
Front Endocrinol (Lausanne); 2023; 14():1061187. PubMed ID: 36817582
[TBL] [Abstract][Full Text] [Related]
4. Validating the 2023 FIGO staging system: A nomogram for endometrioid endometrial cancer and adenocarcinoma.
Feng Y; Miao F; Li Y; Li M; Cao Y
Cancer Med; 2024 May; 13(10):e7216. PubMed ID: 38752451
[TBL] [Abstract][Full Text] [Related]
5. Nomogram Predicts Risk and Prognostic Factors for Bone Metastasis of Pancreatic Cancer: A Population-Based Analysis.
Zhang W; Ji L; Wang X; Zhu S; Luo J; Zhang Y; Tong Y; Feng F; Kang Y; Bi Q
Front Endocrinol (Lausanne); 2021; 12():752176. PubMed ID: 35356148
[TBL] [Abstract][Full Text] [Related]
6. Risk factor analysis and nomogram development and verification for medullary carcinoma of the colon using SEER database.
Yang L; Yu L; Zhou Q; Liu L; Shen N; Li N
Sci Rep; 2024 May; 14(1):11426. PubMed ID: 38763982
[TBL] [Abstract][Full Text] [Related]
7. Metastasis Pattern and Survival Analysis in Primary Small Bowel Adenocarcinoma: A SEER-Based Study.
Gu Y; Deng H; Wang D; Li Y
Front Surg; 2021; 8():759162. PubMed ID: 34950695
[No Abstract] [Full Text] [Related]
8. Conditional survival analysis and real-time prognosis prediction in stage III T3-T4 colon cancer patients after surgical resection: a SEER database analysis.
Zeng H; Xue X; Chen D; Zheng B; Liang B; Que Z; Xu D; Wang X; Lin S
Int J Colorectal Dis; 2024 Apr; 39(1):54. PubMed ID: 38639915
[TBL] [Abstract][Full Text] [Related]
9. Nomograms predicting the overall survival and cancer-specific survival of patients with stage IIIC1 cervical cancer.
Feng Y; Wang Y; Xie Y; Wu S; Li Y; Li M
BMC Cancer; 2021 Apr; 21(1):450. PubMed ID: 33892663
[TBL] [Abstract][Full Text] [Related]
10. Novel nomograms to predict lymph node metastasis and liver metastasis in patients with early colon carcinoma.
Yan Y; Liu H; Mao K; Zhang M; Zhou Q; Yu W; Shi B; Wang J; Xiao Z
J Transl Med; 2019 Jun; 17(1):193. PubMed ID: 31182111
[TBL] [Abstract][Full Text] [Related]
11. Prediction of death probability in adenocarcinoma of the transverse colon: competing-risk nomograms based on 21,469 patients.
Su H; Wang S; Xie S; Huang L; Pan Y; Lyu J
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10435-10452. PubMed ID: 37278827
[TBL] [Abstract][Full Text] [Related]
12. INHBA is a prognostic predictor for patients with colon adenocarcinoma.
Li X; Yu W; Liang C; Xu Y; Zhang M; Ding X; Cai X
BMC Cancer; 2020 Apr; 20(1):305. PubMed ID: 32293338
[TBL] [Abstract][Full Text] [Related]
13. Two Novel Nomograms Predicting the Risk and Prognosis of Pancreatic Cancer Patients With Lung Metastases: A Population-Based Study.
Zhang W; Ji L; Zhong X; Zhu S; Zhang Y; Ge M; Kang Y; Bi Q
Front Public Health; 2022; 10():884349. PubMed ID: 35712294
[TBL] [Abstract][Full Text] [Related]
14. Development and Validation of Prognostic Nomograms to Predict Overall and Cancer-Specific Survival for Patients with Adenocarcinoma of the Urinary Bladder: A Population-Based Study.
Yang Z; Bai Y; Liu M; Hu X; Han P
J Invest Surg; 2022 Jan; 35(1):30-37. PubMed ID: 32851885
[TBL] [Abstract][Full Text] [Related]
15. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
Front Immunol; 2022; 13():947802. PubMed ID: 36405735
[TBL] [Abstract][Full Text] [Related]
16. [Development of A Nomogram for Predicting Survival of Patients
with Primary Mediastinal Germ Cell Tumor Based on SEER Database].
Zheng Z; Wu Z; Hu Y; Zhang Y; Ding C; Zou X
Zhongguo Fei Ai Za Zhi; 2023 Mar; 26(3):193-203. PubMed ID: 37035882
[TBL] [Abstract][Full Text] [Related]
17. Analysis of survival benefit from primary tumor resection and individualized prediction of overall survival for lung cancer patients with bone metastasis: Worth it or not?
Tong Y; Jiang L; Gong Y; Zhu D; Zhao D
Asian J Surg; 2024 Jan; 47(1):333-349. PubMed ID: 37741753
[TBL] [Abstract][Full Text] [Related]
18. Nomograms for Predicting the Risk and Prognosis of Liver Metastases in Pancreatic Cancer: A Population-Based Analysis.
Shi H; Li X; Chen Z; Jiang W; Dong S; He R; Zhou W
J Pers Med; 2023 Feb; 13(3):. PubMed ID: 36983591
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors and individualized nomograms predicting overall survival in stage IV rectal cancer patients with different metastatic status: a SEER-based study.
Ge H; Zhou Z; Li Y; Wang D; Güngör C
Transl Cancer Res; 2022 Sep; 11(9):3141-3155. PubMed ID: 36237239
[TBL] [Abstract][Full Text] [Related]
20. Individualized assessment of risk and overall survival in patients newly diagnosed with primary osseous spinal neoplasms with synchronous distant metastasis.
Tong Y; Huang Z; Jiang L; Pi Y; Gong Y; Zhao D
Front Public Health; 2022; 10():955427. PubMed ID: 36072380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]